Effect of 15-mg Edoxaban on Clinical Outcomes in 3 Age Strata in Older Patients With Atrial Fibrillation

Authors:

Abstract
The prevalence of atrial fibrillation (AF) increases with age, and AF and age are both independent risk factors for stroke.1,2 To prevent cardioembolic stroke in patients with AF, clinical guidelines recommend using direct oral anticoagulants (DOACs), even in older patients.3,4 However, evidence on the use of DOACs in extremely older patients is lacking, and many physicians remain reluctant to prescribe standard doses of DOACs to extremely older patients owing to risk factors for bleeding in this patient group, such as severe kidney impairment, history of bleeding, previous falls, polypharmacy, and frailty.5-7

This publication has 18 references indexed in Scilit: